Skip to content

JOURNAL ARTICLES

2018-2021

Sudasinghe, H.P. and Peiris, D.C.Hypoglycemic and hypolipidemic activity of aqueous leaf extract of Passiflora suberosa L.https://peerj.com/articles/4389/
Bandara, K.R., Padumadasa, C. and Peiris, D.C.Potent antibacterial, antioxidant and toxic activities of extracts from Passiflora suberosa L. leaves.https://peerj.com/articles/4804/
Wickramasinghe, W.T.H.C., Peiris, L.D.C. and Padumadasa, C.Chemical and biological studies of value-added cinnamon products in the Sri Lankan market.http://192.248.32.11/bitstream/handle/123456789/8764/657601411vcat618-Vol.-9-Issue-11-Nov-2018-IJPSR-RA-9966.pdf?sequence=1&isAllowed=y
Jayatilake, P.L. and Munasinghe, H.Antimicrobial activity of cultivable endophytic and rhizosphere fungi associated with “mile-a-minute,” Mikania cordata (Asteraceae).https://www.hindawi.com/journals/bmri/2020/5292571/
Jayatilake, P.L. and Munasinghe, H.In Vitro Determination of Antimicrobial and Hypoglycemic Activities of Mikania cordata (Asteraceae)https://www.hindawi.com/journals/bri/2020/8674708/
Tennakoon, T.S.G., Gunaherath, G.K.B., De Silva, K.T.D., Padumadasa, C., Wijesundara, D.S.A. and Abeysekera, A.M.Auto-oxidation of Ent-beyer-15-en-19-al isolated from the essential oil of the heartwood of Erythroxylum monogynum Roxb.: formation of 15, 16-epoxy-ent-beyeran-19-oic acid and other products.https://link.springer.com/article/10.1186/s13065-020-00671-9
Silva, E.I.P., Jayasingha, P., Senanayake, S., Dandeniya, A. and Munasinghe, D.H.Microbiological study in a gneissic cave from Sri Lanka, with special focus on potential antimicrobial activities.https://digitalcommons.usf.edu/cgi/viewcontent.cgi?article=2343&context=ijs
Wickramaarachchige H.S, Fernando M.M.M.R , Wickramanayake H.M.D.N , Siriwardhene M. A. and Samarakoon D.N.A.W.Unknown antifungal activity of Phyllanthus emblica and Citrus aurantifolia against Candida albicans.RUFARS 2020: University of Ruhuna.
Siriwardhene M. A.Investigation of in vitro anti-inflammatory activity of hexane extract of Costus speciosus leaves.RUFARS 2020: University of Ruhuna.
Dharmasena, W.G.B.P., Udugama, S.S.T.T.A., Wijerathne, S.C. and Munasinghe, D.H.H.Domestication of a wild strain of Ganoderma lucidum mushroom growing in Sri Lanka.Proceedings of the 76th Annual Sessions of the Sri Lanka Association for the Advancement of Science. Sri Lanka Association for the Advancement of Science.
Fernando, H., Kumarasinghe, K., Gunasekara, T., Fernando, S., Jayaweera, P., Soysa, S. and Rajapaksha, S.Cytotoxicity and anticancer activity of few garcinol associated metal systems on BHK- and RD cell lines.In: 13th International Research Conference. General Sir Jhon Kothalawala Defence University, Sri Lanka.
Wijekoon, H., Palliyaguru, N., Gunasekara, T., Fernando, S., Jayaweera, P. and Kumarasinghe, K.Microwave assisted synthesis and investigation of antifungal activity of 3- substituted indolin-2-ones.In: Annual Sessions of the Sri Lanka Association for the Advancement of Science. Sri Lanka Association for the Advancement of Science.
Gunawardene S.L.A., Wickrama W.D.S.A., Kapuwella, K.G.A., Siriwardena, M.A., Sirimuthu, N.M.S., Gunasekara, T.D.C.P.Antimicrobial activity of Mangifera zeylanica stem bark from two climate zones from Sri Lanka.Proceedings of the International Forestry and Environment Symposium Volume 25 (2020)(P. 23).
Gunawardene S.L.A., Sirimuthu, N.M.S., Gunasekara, T.D.C.P., Siriwardena, M.A.Antioxidant activity of Mangifera zeylanica stem bark of different extracts.Proceedings of 8th Ruhuna International Science and Technology Conference (P. 48)
Gunawardene S.L.A., Sirimuthu, N.M.S., Gunasekara, T.D.C.P., Siriwardena, M.A.Sun protection activity of Mangifera zeylanica stem bark of aqueous and methanolic extracts.Proceedings of Research Conference in Health Sciences 2021 (P. 90)

From Traditional Herbal Medicine to the Novel Therapeutics

Sri Lanka has a long history of utilizing herbal materials with unique medicinal properties for the treatment of a vast number of diseases. However, still, it is a field that is to be explored for the development of novel therapeutics to treat life-threatening diseases.